RIMEL REBECCA W 4
4 · BIOTELEMETRY, INC. · Filed Jun 1, 2018
Insider Transaction Report
Form 4
RIMEL REBECCA W
Director
Transactions
- Sale
Common Stock
2018-05-31$42.28/sh−9,338$394,811→ 111,037 total - Exercise/Conversion
Common Stock
2018-05-31$17.67/sh+9,338$165,002→ 120,375 total - Exercise/Conversion
Stock Options (Right to Buy)
2018-05-31−9,338→ 0 totalExercise: $17.67Exp: 2019-05-08→ Common Stock (9,338 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 30, 2018.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $42.10 to $42.90, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F3]The stock options vested in four equal quarterly installments that began on June 30, 2009.